E-LIB Suche - Ergebnisse für: de Langen, A. J

1

PCR181 Health-Related Quality-of-Life of Patients Treated w..:

Sherif, B. ; Besse, B. ; Solomon, B....
Value in Health. 26 (2023) 12 - p. S484 , 2023

Link: https://doi.org/10.1016/..

2

MA13.10 Trastuzumab Deruxtecan in Patients with HER2-Mutant..:

Janne, P. ; Goto, Y. ; Kubo, T....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S148 , 2023

Link: https://doi.org/10.1016/..

3

P2.10-07 ORA-LM: Molecular Analysis in Cerebrospinal Fluid ..:

van der Wel, T. ; Boelens, M.C. ; Jebbink, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S354-S355 , 2023

Link: https://doi.org/10.1016/..

4

Trastuzumab-Emtansine and Osimertinib Combination Therapy t..:

Jebbink, M. ; de Langen, A.J. ; Monkhorst, K....
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100481 , 2023

Link: https://doi.org/10.1016/..

5

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive..:

Cho, B.C. ; Camidge, D.R. ; Lin, J.J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S50-S51 , 2023

Link: https://doi.org/10.1016/..

6

EP08.02-019 Phase 1/2 Study of BLU-701, a Highly Selective ..:

Spira, A. ; Spigel, D.R. ; Camidge, R....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S406 , 2022

Link: https://doi.org/10.1016/..

7

The World's First Full Press Freedom:

Langen, [...] , 2022

Link: https://www.degruyter.co..

8

Update from the ongoing phase 1/2 registrational trial of r..:

Besse, B. ; Springfeld, C. ; Baik, C....
European Journal of Cancer. 174 (2022) - p. S75-S76 , 2022

Link: https://doi.org/10.1016/..

9

Trastuzumab and pertuzumab combination therapy for advanced..:

van Berge Henegouwen, J.M. ; Jebbink, M. ; Hoes, L.R....
European Journal of Cancer. 171 (2022) - p. 114-123 , 2022

Link: https://doi.org/10.1016/..

10

2MO First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in ..:

Gettinger, S. ; Schenker, M. ; De Langen, J....
Immuno-Oncology and Technology. 16 (2022) - p. 100107 , 2022

Link: https://doi.org/10.1016/..

11

The role of surgery in the treatment of oligoprogression af..:

Joosten, P.J.M. ; de Langen, A.J. ; van der Noort, V....
Lung Cancer. 161 (2021) - p. 141-151 , 2021

Link: https://doi.org/10.1016/..

12

PO-1483 Hypofractionated radiotherapy combined with targete..:

van Aken, E.S. ; van der Linden, Y.M. ; Marijnen, C.A....
Radiotherapy and Oncology. 161 (2021) - p. S1214-S1215 , 2021

Link: https://doi.org/10.1016/..

13

Prognostic impact of KRAS mutation status for patients with..:

Noordhof, A.L. ; Damhuis, R.A.M. ; Hendriks, L.E.L....
Lung Cancer. 155 (2021) - p. 163-169 , 2021

Link: https://doi.org/10.1016/..

14

OC-0692: Phase 1 study of olaparib as radiosensitizer for l..:

De Haan, R. ; Van Diessen, J. ; Peulen, H.M.U....
Radiotherapy and Oncology. 152 (2020) - p. S386-S387 , 2020

Link: https://doi.org/10.1016/..

15

Osimertinib treatment for patients with EGFR exon 20 mutati..:

van Veggel, B. ; Madeira R Santos, J.F. Vilacha ; Hashemi, S.M.S....
Lung Cancer. 141 (2020) - p. 9-13 , 2020

Link: https://doi.org/10.1016/..